×







We sell 100% Genuine & New Books only!

Rapid Eye Movement Sleep Behavior Disorder (Hb 2019) at Meripustak

Rapid Eye Movement Sleep Behavior Disorder (Hb 2019) by Schenck C H, Springer

Books from same Author: Schenck C H

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 16973.00/- [ 27.00% off ]

    Seller Price: ₹ 12390.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Schenck C H
    PublisherSpringer
    ISBN9783319901510
    Pages678
    BindingHardbound
    LanguageEnglish
    Publish YearNovember 2018

    Description

    Springer Rapid Eye Movement Sleep Behavior Disorder (Hb 2019) by Schenck C H

    This book describes a sleep disorder belonging to the category of parasomnias (i.e. the sleep behavioral and experiential disorders) characterized by abnormal vocal and motor behaviors in the context of vivid dreams and loss of the customary muscle atonia during the stage of sleep called REM sleep. REM-atonia - one of the defining features of REM sleep, along with rapid-eye-movements and a highly activated brain state - serves a protective function, preventing the dreamer from acting-out dreams and becoming injured. REM sleep behavior disorder (RBD) was first described in 1986 by Schenck and colleagues; since then the understanding of the condition has increased exponentially, also pointing out its strong association with the development of neurodegenerative disorders characterized by alpha synuclein deposition, such as Parkinson's disease, Dementia with Lewy bodies, and Multiple System Atrophy. Furthermore, RBD is now considered one of the earliest markers of ongoing alpha synuclein neurodegeneration, and provides a window of opportunity for testing disease modifying therapies that may slow down or halt the progression of these disorders for which there is currently no cure.



    Book Successfully Added To Your Cart